The FDA agreed that the design of a Phase 3 trial testing privosegtor in optic neuritis could support a future approval ...

"Our decision to treat typically needs to be made on the balance of likelihood, before the diagnosis of an associated disease process can be fully established, with definitive tests for multiple ...

Multiple sclerosis (MS), a multifaceted condition influenced by both genetic and environmental factors, remains a complex diagnostic enigma, especially for diverse populations such as the Hispanic ...

Many people experience vision problems in MS. Learn about common eye symptoms, including eye pain, blurry vision, and double vision.

Genetic analysis combined with consideration of other risk factors could significantly improve early distinction between people with optic neuritis who are likely to develop multiple sclerosis (MS), ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer, ...

A new therapeutic agent tested in a mouse model of multiple sclerosis (MS) produced anti-inflammatory activity and prevented loss of cells in the optic nerve, according to a new study by researchers ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Fampridine resulted in no significant observed ...

Optic Neuritis: Clinical Features Optic neuritis refers to inflammation of the optic nerve. The term may be used broadly in reference to many causes of optic nerve inflammation including systemic ...

Optic neuritis [ON] is generally identified as the most frequent potential risk factor associated with future development of multiple sclerosis [ms]. Whereas coherency in case of the adult disease is ...